Author

Javier Alcedo 1

1 Hospital Miguel Servet,Zaragoza,Spain

ASSOCIATION BETWEEN HELICOBACTER PYLORI INFECTION AND EOSINOPHILIC ESOPHAGITIS: RESULTS OF A MULTICENTER PROSPECTIVE EUROPEAN STUDY

Javier Molina Infante, Edoardo Vincenzo Savarino, Ines Modolell, Roberto Penagini, Alicia Prieto-Garcia, Ottavia Bartolo, Aurelio Mauro, Javier Alcedo, Jose Antonio Pajares Diaz, Elisa Marabotto, José Luis Domínguez Jiménez, Salvatore Tolone, Carlos Guarner-Argente, Marianette Carolina Murzi Pulgar, Nicola de Bortoli, Ana M

DIAGNOSTIC DELAY REDUCES AND DIAGNOSTIC PRECISION INCREASES ALONG TIME FOR EOSINOPHILIC ESOPHAGITIS: AN ANALYSIS FROM THE EOE CONNECT REGISTRY ON THE IMPACT ON CLINICAL PRACTICE GUIDELINES TO IMPROVE DISEASE AWARENESS IN EUROPE

M Pilar Navarro Sánchez, Emilio Jose Laserna-Mendieta, Danila Guagnozzi, Sergio Casabona-Francés, Maria Antonia Perello, Susana de la Riva, L. Blas-Jhon, Isabel Pérez-Martínez, Jesús Barrio Andrés, Anne Lund Krarup, Antonio Guardiola Arévalo, Javier Alcedo, Carolina Gutiérrez-Junquera, Edoardo Vincenzo Savarino, M.T. Palomequ

EFFECTIVENESS OF FIRST-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

Maria Caldas, Ángeles Pérez-Aísa, Manuel Castro Fernandez, Luis Bujanda, Alfredo J. Lucendo, José M. Huguet, Javier Molina Infante, Luis Fernández Salazar, Juan Ortuño, Manuel Domínguez Cajal, Pedro Almela, Josep M Botargués, Judith Gomez, Cristobal de la Coba, Liliana Pozzati, Merce Barenys, Miguel Fernandez-Bermejo, Javi

EFFICACY OF PROTON-PUMP INHIBITOR THERAPY FOR EOSINOPHILIC OESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Emilio Jose Laserna-Mendieta, Sergio Casabona-Francés, Danila Guagnozzi, Edoardo Vincenzo Savarino, Maria Antonia Perello, Antonio Guardiola Arévalo, Jesús Barrio Andrés, Isabel Pérez-Martínez, Anne Lund Krarup, Javier Alcedo, S. De la Riva, Esther Rey-Iborra, Cecilio Santander, Ángel Arias Arias, Alfredo J. Lucendo

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Emilio Jose Laserna-Mendieta, M Pilar Navarro Sánchez, Sergio Casabona-Francés, Isabel Pérez-Martínez, Edoardo Vincenzo Savarino, Anne Lund Krarup, Danila Guagnozzi, Elena Betoré Glaría, Antonio Guardiola Arévalo, Maria Antonia Perello, Jesús Barrio Andrés, Francesca Racca, Leonardo Blas-Jhon, Carolina Gutiérrez-Junquera, Son

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

ELENA RESINA SIERRA, María G. Donday, Samuel Jesús Martínez-Domínguez, Emilio Jose Laserna-Mendieta, Angel Lanas, Alfredo J. Lucendo, Marta Sánchez-Luengo, Noelia Alcaide Suárez, Valle Bachiller, Luisa Luisa De La Peña-Negro, Luis Bujanda Fernández de Piérola, Marta Gómez-Ruiz de Arbulo, Javier Alcedo, Ángeles Pérez-Aísa, Rau

IMPLEMENTATION OF PROTON PUMP INHIBITOR DEPRESCRIPTION PROTOCOL AT HOSPITAL DISCHARGE: THE DE-PIBP PROJECT

Paula García Cámara, Luis Javier Lamuela, Mónica Llorente-Barrio, Olivia Sierra, María Rosario Monzón, Javier Alcedo, José Miguel Arbones-Mainar, Vanesa Bernal

MEDIUM- AND LONG-TERM RESULTS OF TREATMENT WITH LANREOTIDE IN CASES OF CHRONIC OR RECURRENT OBSCURE GASTROINTESTINAL BLEEDING OR DUE TO GASTROINTESTINAL ANGIODYSPLASIAS

Santiago Frago-Larramona, Leticia Ollero, Maria Lazaro, Edgar Peña-Galo, Natalia De la Llama, Javier Alcedo

NON-BISMUTH QUADRUPLE CONCOMITANT THERAPIES IN THE ERADICATION OF HELICOBACTER PYLORI: STANDARD VS. OPTIMIZED (14 DAYS, HIGH-DOSE PPI) REGIMENS IN CLINICAL PRACTICE.

Adrian Gerald McNicholl, Javier Molina Infante, Fernando Bermejo, Y. Harb, L Ferrer-Barcelo, Ines Modolell, R Antón, A Perez-Aisa, Javier Alcedo, María Mercé Barenys de Lachan, Miguel Fernandez-Bermejo, Alicia Algaba, N Fernandez-Moreno, J Barrio, J. Gomez, L Pozzati, Juan Ortuño, Luis Rodrigo, P Canelles, J. M. Huguet-M

PROSPECTIVE COMPARATIVE STUDY OF TWO FIRST-LINE REGIMENS FOR HELICOBACTER PYLORI ERADICATION: 14-DAYS NON-BISMUTH QUADRUPLE OPTIMIZED CONCOMITANT THERAPY VERSUS 10-DAYS BISMUTH-CONTAINING QUADRUPLE THERAPY USING A THREE-IN-ONE CAPSULE.

Javier Alcedo, Marta Gracia, Paula García Cámara, Carmen Palacín, Santiago Frago, Isabel Aured, Lara Luzón, Sonia Gallego, Cristina Jimeno-Ayllón, Dolores Pérez-Milián, Dolores Villafranca

Item 1 - 10 / 14
1
2